[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

AU2001231849A1 - Use of dehydroepiandrosterone and/or precursors or derivatives thereof to improve papery aspect of the skin - Google Patents

Use of dehydroepiandrosterone and/or precursors or derivatives thereof to improve papery aspect of the skin

Info

Publication number
AU2001231849A1
AU2001231849A1 AU2001231849A AU3184901A AU2001231849A1 AU 2001231849 A1 AU2001231849 A1 AU 2001231849A1 AU 2001231849 A AU2001231849 A AU 2001231849A AU 3184901 A AU3184901 A AU 3184901A AU 2001231849 A1 AU2001231849 A1 AU 2001231849A1
Authority
AU
Australia
Prior art keywords
skin
dehydroepiandrosterone
precursors
derivatives
improve
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001231849A
Inventor
Olivier De Lacharriere
Stephanie Nouveau
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Publication of AU2001231849A1 publication Critical patent/AU2001231849A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The present invention relates to the use of DHEA and/or of at least one precursor or derivative thereof in or for the manufacture of a composition for topical application to the skin, as an agent for preventing or reducing the weathered appearance of the skin.
AU2001231849A 2000-01-12 2001-01-08 Use of dehydroepiandrosterone and/or precursors or derivatives thereof to improve papery aspect of the skin Abandoned AU2001231849A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0000349 2000-01-12
FR0000349A FR2803513B1 (en) 2000-01-12 2000-01-12 USE OF DHEA AND / OR ITS PRECURSORS OR DERIVATIVES TO IMPROVE THE PAPYRACE OF THE SKIN
PCT/FR2001/000043 WO2001051021A2 (en) 2000-01-12 2001-01-08 Use of dehydroepiandrosterone or some derivatives thereof to improve papery aspect of the skin

Publications (1)

Publication Number Publication Date
AU2001231849A1 true AU2001231849A1 (en) 2001-07-24

Family

ID=8845833

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001231849A Abandoned AU2001231849A1 (en) 2000-01-12 2001-01-08 Use of dehydroepiandrosterone and/or precursors or derivatives thereof to improve papery aspect of the skin

Country Status (9)

Country Link
US (1) US20030124084A1 (en)
EP (1) EP1250121B1 (en)
JP (1) JP2003519647A (en)
AT (1) ATE323464T1 (en)
AU (1) AU2001231849A1 (en)
DE (1) DE60118882T2 (en)
ES (1) ES2262623T3 (en)
FR (1) FR2803513B1 (en)
WO (1) WO2001051021A2 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2811563B1 (en) * 2000-07-13 2003-06-20 Oreal COMPOSITION, ESPECIALLY COSMETIC, COMPRISING DHEA AND / OR A PRECURSOR OR DERIVATIVE, AND AT LEAST ONE COMPOUND INCREASING THE SYNTHESIS OF GLYCOSAMINOGLYCANS
FR2827767B1 (en) * 2001-07-27 2005-08-19 Oreal NANOCAPSULES CONTAINING A STEROID AND COMPOSITION, ESPECIALLY COSMETIC, COMPRISING THE SAME
FR2827766A1 (en) * 2001-07-27 2003-01-31 Oreal Composition useful as a cosmetic product comprises an aqueous dispersion of liposomes containing a dehydroepiandrosterone compound
FR2828100B1 (en) * 2001-08-02 2004-09-24 Galderma Res & Dev REVERSE EMULSION COMPOSITION CONTAINING DHEA AND / OR ITS PRECURSORS OR DERIVATIVES, AND ITS USE IN COSMETICS AND DERMATOLOGY
DE10155200A1 (en) * 2001-11-12 2003-05-28 Skinlab Gmbh Use of cholesterol, substances containing cholesterol or substances that increase cholesterol in cosmetic and dermatological preparations for the purpose of UV protection
FR2838344B1 (en) * 2002-04-12 2005-06-17 Oreal USE OF A SAPOGENINE, OR A NATURAL EXTRACT CONTAINING, TO ENHANCE THE RIDES AND RIDULES OF EXPRESSION
US7354956B2 (en) * 2002-04-12 2008-04-08 L'oreal Composition containing a sapogenin and use thereof
WO2004105719A2 (en) * 2003-05-23 2004-12-09 Ninapharm (S.A.R.L) Product for epidermal protection
FR2904549B1 (en) * 2006-08-03 2012-12-14 Sederma Sa COMPOSITION COMPRISING SARSASAPOGENIN
WO2008126319A1 (en) * 2007-03-30 2008-10-23 Ibiden Co., Ltd. Process for production of porous silicon carbide sintered compacts

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3981867A (en) * 1975-03-17 1976-09-21 Beauvoir Max G Process for obtaining sapogenin particularly hecogenin from plant material such as agave sisalana leaves
US4389418A (en) * 1981-02-25 1983-06-21 S. C. Johnson & Son, Inc. Skin care composition
US4567037A (en) * 1984-11-20 1986-01-28 Revlon, Inc. Fatty acid diesters
US5166176A (en) * 1986-12-29 1992-11-24 Obagi Zein E Composition for healing damaged skin
US5723149A (en) * 1990-11-21 1998-03-03 Lvmh Recherche Use of medicago saponins for the preparation of cosmetic or pharmaceutical compositions, especially dermatological compositions, promoting renewal of the epidermis, stimulating hair regrowth or delaying hair loss
FR2729854A1 (en) * 1995-01-26 1996-08-02 Oreal USE OF DEHYDROEPI-ANDROSTERONE SULFATE IN A COSMETIC OR DERMATOLOGICAL COMPOSITION
US5736537A (en) * 1995-09-12 1998-04-07 Estee Lauder, Inc. Dehydroep:androsterone sailcylate useful against skin atrophy
US6168798B1 (en) * 1997-02-03 2001-01-02 Bristol-Myers Squibb Company Non-irritating composition for treating acne and other skin conditions
US6022977A (en) * 1997-03-26 2000-02-08 Dupont Pharmaceuticals Company Dynamic resolution of isoxazoline thioesters to isoxazoline carboxylic acids
EP0908183A1 (en) * 1997-10-08 1999-04-14 Institute For Advanced Skin Research Inc. Dehydroepiandrosterone or derivatives thereof for increasing the content of hyaluronic acid in skin
US6733802B1 (en) * 1997-12-17 2004-05-11 Fortune Bio-Tech Limited Natural azadirachtin composition
EP1041964A4 (en) * 1998-09-10 2003-09-03 Avon Prod Inc Method and compositions for reducing dermatological aging and for reducing bruising
FR2817747B1 (en) * 2000-12-11 2004-12-03 Oreal USE OF AT LEAST ONE SAPOGENIN, OR A NATURAL EXTRACT CONTAINING IT, TO PREVENT THE SIGNS OF SKIN AGING
US6562581B2 (en) * 2001-08-31 2003-05-13 Portascience Method for quantitative determination of glycated hemoglobin

Also Published As

Publication number Publication date
FR2803513B1 (en) 2003-12-19
WO2001051021A3 (en) 2002-03-21
WO2001051021A2 (en) 2001-07-19
DE60118882D1 (en) 2006-05-24
US20030124084A1 (en) 2003-07-03
EP1250121A2 (en) 2002-10-23
JP2003519647A (en) 2003-06-24
ATE323464T1 (en) 2006-05-15
ES2262623T3 (en) 2006-12-01
EP1250121B1 (en) 2006-04-19
DE60118882T2 (en) 2006-11-30
FR2803513A1 (en) 2001-07-13

Similar Documents

Publication Publication Date Title
AU2001231189A1 (en) Transdermal anesthetic and vasodilator composition and methods for topical administration
AU9163701A (en) Topical composition containing at least one vitamin D or one vitamin D analogue and at least one corticosteroid
AU2001286578A1 (en) Topical antioxidant having vitamin c and method of combination with topical agent by user
CA2370565A1 (en) Dermally applicable vitamin d-containing pharmaceutical compositions
HK1128005A1 (en) Compositions comprising glyceryl salicylate compounds
AU2003301198A1 (en) Topical use of post-application expanding cosmetic composition
WO2006119283A3 (en) Anti-odor compositions and therapeutic use
AU2001282399A1 (en) Resorcinol derivatives
AU2001231849A1 (en) Use of dehydroepiandrosterone and/or precursors or derivatives thereof to improve papery aspect of the skin
WO2004052308A3 (en) Topical anti-infective formulations
AU5792399A (en) Stable ascorbic acid preparation for topical use
WO2002019982A3 (en) Cosmetic composition and method for reducing or preventing wrinkling
WO2004087083A3 (en) Reduction of hair growth
AU2001267622A1 (en) Composition, in particular cosmetic, comprising dhea and/or a precursor or derivative thereof, combined with at least no-synthase inhibitor
ZA200005413B (en) Cholesterol sulfate compositions for enhancement of stratum corneum function.
FR2811563B1 (en) COMPOSITION, ESPECIALLY COSMETIC, COMPRISING DHEA AND / OR A PRECURSOR OR DERIVATIVE, AND AT LEAST ONE COMPOUND INCREASING THE SYNTHESIS OF GLYCOSAMINOGLYCANS
SI1347764T1 (en) Gel composition based on alcohol for the treatment of hypogonadism through transscrotal application
AU7598000A (en) Antimicrobial topical composition and methods
WO2004091568A3 (en) Cosmetic composition of two polysaccharides based on fucose and rhamnose
AU2001269730A1 (en) Low carbohydrate compositions, kits thereof, and methods of use
AU2003246844A1 (en) Use of cyclodextrine as a pearly-lustring agent and pearly lustred compositions
AU2002239739A1 (en) Compositions, methods and kits relating to remodelin
AU2001267621A1 (en) Composition, in particular cosmetic, comprising dhea and/or a precursor or derivative thereof, combined with at least glycation inhibiting agent
AU2002212489A1 (en) Veterinary composition for the topical treatment of traumatized or inflamed skin
AU2001235527A1 (en) Use of orally administered dehydroepiandrosterone, precursors and derivatives thereof in order to improve the papery aspect of the skin